(prof. S. Guccione) AVVISO DI SEMINARIO "Identifying modifier genes as therapeutic targets for genetic disorders".

Giovedì 18 Dicembre 2024- ORE 11,00

Dr. Vincent Blomen  is the Senior Director of Target Discovery at Scenic Biotech. He completed his PhD at Utrecht University, where he worked in the lab of one of Scenic’s founders. During his PhD, he contributed to the development of a platform to identify genetic interactions, which is now used at Scenic to discover modifier genes. In his current role, Vincent oversees the discovery efforts of new drug targets using Scenic’s proprietary platform.